☰

Melissa S. DeRycke, Ph.D. - Publications

Affiliations: 
2010 Microbiology, Immunology and Cancer Biology University of Minnesota, Twin Cities, Minneapolis, MN 
Area:
Oncology
Tree Info Similar researchers PubMed Report error

8 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2017 DeRycke MS, Gunawardena S, Balcom JR, Pickart AM, Waltman LA, French AJ, McDonnell S, Riska SM, Fogarty ZC, Larson MC, Middha S, Eckloff BW, Asmann YW, Ferber MJ, Haile RW, et al. Targeted sequencing of 36 known or putative colorectal cancer susceptibility genes. Molecular Genetics & Genomic Medicine. 5: 553-569. PMID 28944238 DOI: 10.1002/Mgg3.317  0.417
2016 Boylan KLM, Buchanan PC, Shukla D, DeRycke M, Walcheck B, APNS. Abstract B58: Functional analysis of the cell adhesion molecule Nectin-4 in the unique tumor microenvironment of ovarian cancer. Clinical Cancer Research. 22. DOI: 10.1158/1557-3265.Ovca15-B58  0.462
2013 Derycke MS, Charbonneau B, Preston CC, Kalli KR, Knutson KL, Rider DN, Goode EL. Toward understanding the genetics of regulatory T cells in ovarian cancer. Oncoimmunology. 2: e24535. PMID 23894717 DOI: 10.4161/Onci.24535  0.406
2013 Charbonneau B, Goode EL, Kalli KR, Knutson KL, Derycke MS. The immune system in the pathogenesis of ovarian cancer. Critical Reviews in Immunology. 33: 137-64. PMID 23582060 DOI: 10.1615/Critrevimmunol.2013006813  0.335
2013 Xu J, Lange EM, Lu L, Zheng SL, Wang Z, Thibodeau SN, Cannon-Albright LA, Teerlink CC, Camp NJ, Johnson AM, Zuhlke KA, Stanford JL, Ostrander EA, Wiley KE, Isaacs SD, ... ... DeRycke MS, et al. HOXB13 is a susceptibility gene for prostate cancer: results from the International Consortium for Prostate Cancer Genetics (ICPCG). Human Genetics. 132: 5-14. PMID 23064873 DOI: 10.1007/S00439-012-1229-4  0.316
2010 Derycke MS, Pambuccian SE, Gilks CB, Kalloger SE, Ghidouche A, Lopez M, Bliss RL, Geller MA, Argenta PA, Harrington KM, Skubitz AP. Nectin 4 overexpression in ovarian cancer tissues and serum: potential role as a serum biomarker. American Journal of Clinical Pathology. 134: 835-45. PMID 20959669 DOI: 10.1309/Ajcpgxk0Fr4Mhihb  0.506
2009 DeRycke MS, Andersen JD, Harrington KM, Pambuccian SE, Kalloger SE, Boylan KL, Argenta PA, Skubitz AP. S100A1 expression in ovarian and endometrial endometrioid carcinomas is a prognostic indicator of relapse-free survival. American Journal of Clinical Pathology. 132: 846-56. PMID 19926575 DOI: 10.1309/Ajcptk87Emmikpfs  0.503
2008 Tchagang AB, Tewfik AH, DeRycke MS, Skubitz KM, Skubitz AP. Early detection of ovarian cancer using group biomarkers. Molecular Cancer Therapeutics. 7: 27-37. PMID 18187805 DOI: 10.1158/1535-7163.Mct-07-0565  0.441
Show low-probability matches.